SCND OTC
Scientific Industries, Inc.
1W: +3.6%
1M: -2.9%
3M: +34.0%
YTD: +38.8%
1Y: +11.0%
3Y: -83.6%
5Y: -92.6%
$0.78
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$11M
+6.1% ▲
5Y CAGR: +1.0%
Gross Profit
$5M
+10.0% ▲
5Y CAGR: +1.6%
Operating Income
-$7M
-13.3% ▼
Net Income
-$6M
-11.5% ▼
EPS (Diluted)
$-0.61
+22.4% ▲
EBITDA
-$6M
-14.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $9M | $10M | $10M | $11M | $11M |
| YoY Growth | -16.0% | +14.1% | +7.2% | +6.1% | — |
| Cost of Revenue | $5M | $5M | $6M | $6M | $6M |
| Gross Profit | $4M | $5M | $5M | $5M | $5M |
| Gross Margin | 45.0% | 50.9% | 44.3% | 45.9% | 44.2% |
| R&D Expenses | $1M | $2M | $3M | $4M | $3M |
| SG&A Expenses | $4M | $8M | $10M | $11M | $8M |
| Operating Expenses | $5M | $10M | $13M | $14M | $11M |
| Operating Income | -$1M | -$5M | -$8M | -$9M | -$7M |
| Operating Margin | -13.2% | -48.2% | -78.0% | -83.3% | -62.0% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$1M | -$4M | -$8M | -$9M | -$6M |
| Tax Expense | -$437K | -$945K | $2M | -$3K | $0 |
| Net Income | -$703K | -$3M | -$8M | -$9M | -$6M |
| Net Margin | -8.2% | -31.8% | -77.8% | -81.8% | -60.2% |
| EPS (Diluted) | $-0.22 | $-0.47 | $-1.16 | $-0.90 | $-0.61 |
| EBITDA | -$979K | -$4M | -$7M | -$9M | -$6M |
| Shares Outstanding | 3M | 7M | 7M | 10M | 11M |